13 non-profits urge Senate HELP Committee to block floor amendments to 21st Century Cures Act counterpart

Before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) presents a legislative package of healthcare reforms to the Senate floor for an up-or-down vote, 13 consumer, patient and health non-profit groups sent a letter to HELP Chairman and Ranking Member to ensure that the final legislative package includes only those bills that the HELP Committee reviewed in mark-up sessions.

Continue Reading

Uncategorized

122 experts defend Colombia’s right to issue compulsory license on imatinib in face of U.S. pressure

(More on Colombia here: /colombia)

On May 16, 2016, 122 health, trade, and intellectual property experts defended the Colombian government’s right to issue a compulsory license on imatinib, an expensive leukemia drug that is being sold at a high price by the Swiss drug company Novartis, in a letter to Colombian President Juan Manuel Santos.

Continue Reading

Uncategorized

2016: MeiraGTx, NIH license of patents on AAV­Mediated Aquaporin Gene Transfer To Treat Sjögren’s Syndrome

(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) May 16th, 2016 Sally Hu, Ph.D., M.B.A., Senior Licensing and Patenting Manager, Office of Technology Transfer and Innovation Access, National Institute of Dental and Craniofacial… Continue Reading